
Diagnosis of Renal Cell Carcinoma (RCC): 5 Things to Know
Aug 19, 2025 · From artificial intelligence radiomics and liquid biopsy to simple blood tests, a full armamentarium is key to early and accurate RCC diagnosis. Stay vigilant with these five things to know.
Everolimus Offers No Survival Benefit in Non–Clear Cell RCC
Aug 30, 2024 · A secondary analysis of the EVEREST trial found that adjuvant everolimus did not provide a recurrence-free or overall survival benefit in patients with localized non–clear cell RCC.
ImmunoPET Tracer Can Detect Common Kidney Cancers - Medscape
Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to diagnose.
Q&A – Advanced RCC: A Potential New Treatment Target - Medscape
Aug 22, 2025 · Dr Karl J. D’Silva reviews the evolution of systemic therapies in renal cell carcinoma and a possible new treatment target.
RCC: 5 Things to Know About the Latest Developments - Medscape
Mar 8, 2024 · Clear-cell RCC, the predominant form of kidney cancer, is closely associated with mutations in the VHL gene, a crucial tumor suppressor located on band 3p25.
Hereditary RCC: Early Diagnosis and Management - Medscape
Jul 8, 2024 · VHL is an autosomal dominant disease associated with angiogenesis and tumorigenesis that translates into patients with clear cell RCC and clinical manifestations, including central nervous …
Renal Cell Carcinoma - Medscape
Sep 18, 2025 · Renal Cell Carcinoma : Review in-depth clinical information, latest medical news, and guidelines on renal cell carcinoma and kidney cancer. Review current articles about kidney cancer …
Q&A: Immunotherapy in Renal Cell Carcinoma (RCC) - Medscape
Mar 8, 2024 · A collaboration and conversation between Medscape and Dr Karl D'Silva on the impact of immunotherapy in renal cell carcinoma.
Case 6: Hereditary Non-Clear Cell RCC - Medscape
Aug 22, 2023 · The e-Tumor Boards, a video series collaboration with Memorial Sloan Kettering Cancer Center, gives physicians an inside look into a virtual, multidisciplinary renal cell carcinoma tumor …
Renal Cell Carcinoma Highlights From ASCO GU 2025 - Medscape
Mar 6, 2025 · Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new …